ArticleKidney international supplements2021

Hypoxia-inducible factor-prolyl hydroxylase inhibitors in the treatment of anemia of chronic kidney disease.

Volker H HaasePubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.